Human T-lymphotropic virus type-1 (HTLV-1) is a complex retrovirus that causes adult T-cell leukemia/lymphoma (ATL) and is implicated in a variety of lymphocyte-mediated disorders. HTLV-1 pX ORF II encodes two proteins, p13 II and p30 II whose roles are beginning to be defined in the virus life cycle. Previous studies indicate the importance of these viral proteins in the ability of the virus to maintain viral loads and persist in an animal model of HTLV-1 infection. Intriguing new studies indicate that p30 II is a multifunctional regulator that differentially modulates CREB and Taxresponsive element-mediated transcription through its interaction with CREB-binding protein (CBP)/p300 and specifically binds and represses tax/rex mRNA nuclear export. A new study characterized the role of p30 II in regulation of cellular gene expression using comprehensive human gene arrays. Interestingly, p30 II is an overall repressor of cellular gene expression, while selectively favoring the expression of regulatory gene pathways important to T lymphocytes. These new findings suggest that HTLV-1, which is associated with lymphoproliferative diseases, uses p30 II to selectively repress cellular and viral gene expression to favor the survival of cellular targets ultimately resulting in leukemogenesis.
The complex sequence of events set in motion by human T-lymphotropic virus type 1 (HTLV-1) to cause proliferation and ultimately transformation of T lymphocytes is beginning to be unraveled. Only recently has it become clear that viral encoded proteins, the so-called "accessory" gene products of this complex retrovirus, play an integral role in the pathogenic process. In addition to the structural and enzymatic gene products, HTLV-1 encodes regulatory and accessory proteins from four open reading frames (ORF) in the pX region between env and the 3' long terminal repeat (LTR) of the provirus [1, 2] . The well studied Rex and Tax positive regulators are encoded in the ORF III and IV, respectively. Rex plays a critical role in nuclear export of unspliced or singly spliced viral mRNA [3, 4] . Tax orchestrates multiple interactions with cellular transcription factors and activates transcription from the viral promoter and modulates the transcription or activity of numerous cellular genes involved in cell growth and differentiation, cell cycle control, and DNA repair [5, 6] . Recent studies have indicated novel roles for pX ORF I and II gene products in the replication of HTLV-1 [7] [8] [9] . Although the study of these gene products were largely bypassed by virologists until the mid 1990's, they intensified when infectious molecular clones provided the tools to better understand their role in vivo. Both HTLV-1 pX ORF I and II mRNAs have been detected in infected cell lines and blood leukocytes from HTLV-1-infected subjects including ATL and HAM/TSP patients [10, 11] . Also, immune responses of HTLV-1 infected patients and asymptomatic carriers indicate that these proteins are expressed in vivo [12] [13] [14] .
Molecular clones of HTLV-1 with selective mutations of ORF I and II have revealed the requirement of p12 I and p13 II /p30 II in the establishment of infection and maintenance of viral loads in a rabbit model of infection [15] [16] [17] . The nuclear and nucleolar localizing p30 II has minimal homology to transcription factors Oct-1 and -2, Pit-1, and POU-M1 [18] [19] [20] [21] . In addition, the protein co-localizes with p300 in the nucleus and physically interacts with CREB binding protein (CBP)/p300 and differentially modulates cAMP responsive element (CRE) and Tax response element-mediated transcription [21, 22] . Intriguing recent reports also indicate a post-transcriptional role of HTLV-1 p30 II and HTLV-2 p28 II (homologous protein encoded in the HTLV-2 pX ORF II region), in repressing the export of tax/rex mRNA from the nucleus [23, 24] . Thus, it appears that HTLV-1 has yet another multifunctional protein with transcriptional and post-transcriptional roles in regulating viral gene expression.
Microarrays are important tools to gain insight into changes in gene expression profiles of virus-infected cells. This approach has been primarily used to investigate gene expression in HTLV-1-immortalized/transformed cell lines or in cells from ATL patients [25] [26] [27] [28] [29] . In the report by Michael et al. [30] the authors used the Affymetrix U133A human gene chip to test the role of HTLV-1 p30 II as a regulator of gene expression in Jurkat T cells. They identified alterations in gene expression profiles unique to cell cycle regulation, apoptosis, and T lymphocyte signaling/activation. Although p30 II expression, as might be expected from earlier reports, resulted in a general repressive pattern of gene expression, their data indicated that the viral protein selectively spared or enhanced NFAT, NFκB, and AP-1 mediated transcription in T cells undergoing costimulation. Signaling pathways primarily affected by p30 II as measured by luciferase reporters included both NFAT and NFκB, which increased from approximately 3 to 11 fold, depending on co-stimulatory treatment. Overall, this study supports earlier reports on the repressive role of HTLV-1 p30 II in gene expression [21] [22] [23] [24] and reveals new potential mechanisms by which p30 II may play a role in HTLV-1 replication (figure 1). The effects of p30 II appear to overlap or counteract the influence of other HTLV-1 regulatory proteins like Tax or other accessory proteins such as p12 I . Further studies to test if these proteins act coordinately or synergistically will undoubtedly shed light on this issue. It is possible that HTLV-1 employs selective use of these viral proteins during various stages of the infection to promote cell proliferation, a hallmark of the diseases associated with the deltaretrovirus family. Whatever the outcome of these studies, it is clear that "accessory" proteins, like p30 II , may have "essential" roles in the life cycle of HTLV-1. 
